药物信息为Ifosfamide Injection (Teva Parenteral Medicines, Inc): WARNINGS
- WARNINGS
- DESCRIPTION
- CLINICAL PHARMACOLOGY
- INDICATIONS AND USAGE
- CONTRAINDICATIONS
- ADVERSE REACTIONS
- OVERDOSAGE
- DOSAGE AND ADMINISTRATION
- HOW SUPPLIED
- REFERENCES
- PRINCIPAL DISPLAY PANEL - 20 mL Single Dose Vial
- PRINCIPAL DISPLAY PANEL - 60 mL Single Dose Vial
- 外部链接相关的Ifosfamide Injection (Teva Parenteral Medicines, Inc)
Ifosfamide injection should be administered under the supervision of a qualified physician experienced in the use of cancer chemotherapeutic agents. Urotoxic side effects, especially hemorrhagic cystitis, as well as CNS toxicities such as confusion and coma have been associated with the use of ifosfamide. When they occur, they may require cessation of ifosfamide therapy. Severe myelosuppression has been reported. (See ADVERSE REACTIONS section.)
- Drug Information Provided by National Library of Medicine (NLM).
